SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-006673
Filing Date
2019-05-09
Accepted
2019-05-09 16:16:37
Documents
85
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 992130
2 ex10-2.htm EX-10.2 72435
3 ex31-1.htm EX-31.1 17674
4 ex31-2.htm EX-31.2 17478
5 ex32-1.htm EX-32.1 9365
  Complete submission text file 0001493152-19-006673.txt   6134273

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE btx-20190331.xml EX-101.INS 995945
7 XBRL SCHEMA FILE btx-20190331.xsd EX-101.SCH 76079
8 XBRL CALCULATION FILE btx-20190331_cal.xml EX-101.CAL 95441
9 XBRL DEFINITION FILE btx-20190331_def.xml EX-101.DEF 410795
10 XBRL LABEL FILE btx-20190331_lab.xml EX-101.LAB 509071
11 XBRL PRESENTATION FILE btx-20190331_pre.xml EX-101.PRE 449615
Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 5105213390
BIOTIME INC (Filer) CIK: 0000876343 (see all company filings)

IRS No.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12830 | Film No.: 19810758
SIC: 2836 Biological Products, (No Diagnostic Substances)